Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPF222Hu01-Recombinant Breast Carcinoma Amplified Sequence 2 (BCAS2)
Recommended Usage
Western blotting: 0.01-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
